Chimera Guard Patch
Product Images NDC 85761-158

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 3 technical images submitted to the FDA as part of the official labeling for Chimera Guard (NDC 85761-158). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Hangzhou Rongna Health Technology Co., Ltd., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

158-15 (85761 158 15)

158-15 (85761 158 15)
This is a product description for Lidocaine Pain Relieving Patches, containing Lidocaine 4%, a topical anesthetic for temporary pain relief. The patch is designed for single-use application, odor-free, and no-mess. The directions include cleaning and drying the affected area before applying the patch for up to 12 hours. It is advised to consult a physician for children under 12 years of age and to store the patches in a clean, dry place away from direct sunlight. The patch should be discarded after a single use. Additionally, the warning section specifies not to use more than one patch at a time, not to use on cut, irritated, or swollen skin, and not to use for more than one week without consulting a doctor. It also states the adverse effects that may occur if the patch is ingested by children or pets. If there is worsening condition, redness, irritation, persisting symptoms after 7 days, or signs of skin injury, it is recommended to stop use and consult a doctor. Pregnant or breastfeeding individuals should seek advice from a healthcare professional before use.*
FDA Label Image

158-30 (85761 158 30)

158-30 (85761 158 30)
This text is about a lidocaine pain relieving patch that provides temporary relief from pain. The patch is easy to apply and remove, and it is odor-free. The instructions on how to use the patch are provided, along with warnings and precautions. It includes information on the active and inactive ingredients, directions for use, and what to do in case of adverse effects or ingestion. It also recommends consulting a physician for children under 12 years of age. The patch is single-use and should be discarded after 12 hours. The product website and social media accounts are mentioned at the end of the text.*
FDA Label Image

Patch (Patch)

Patch (Patch)
This is a description of a Guard Maximum Strength Lidocaine Pain Relieving Patch. The patch contains Lidocaine 4% as a topical anesthetic for temporary relief of pain. The patch is no-mess, single-use application, odor-free, and designed to stay put with a flexible design. The directions for use include cleaning and drying the affected area, carefully applying the patch, and discarding after single use. Warnings include not using more than one patch at a time, avoiding contact with eyes, and consulting a doctor if symptoms persist. The product includes active and inactive ingredients, storage instructions, and contact information for the manufacturer. This product is not manufactured by Aspercreme®Lidocaine Patch but by Hangzhou Rongna Health Technology Co., Ltd in China with child-resistant packaging. Please consult a healthcare professional before use if pregnant or breastfeeding and keep out of reach of children and pets.*

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.